Indeed, a very recent study showed that CFIm functions within phase-separated compartments, and that this process is perturbed by the Clk2 kinase-dependent phosphorylation in cancer cells, leading to effective depletion of CFIm in these cells (Liu et al., 2023). The gene discussed is CPSF6; the disease is cancer.